Health Biotchnology Financials
| SHPCX Fund | USD 13.02 0.03 0.23% |
Health |
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.
Health Biotchnology Fund Summary
Health Biotchnology competes with Transamerica Financial, Prudential Financial, John Hancock, Putnam Global, and Rmb Mendon. The fund will normally invest at least 80 percent of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value . Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends.Specialization | Health, Large |
| Instrument | USA Mutual Fund View All |
| Exchange | NMFQS Exchange |
| Business Address | Saratoga Advantage Trust |
| Mutual Fund Family | Saratoga |
| Mutual Fund Category | Health |
| Benchmark | Dow Jones Industrial |
| Phone | 800 807 3863 |
| Currency | USD - US Dollar |
Health Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Health Biotchnology's current stock value. Our valuation model uses many indicators to compare Health Biotchnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Health Biotchnology competition to find correlations between indicators driving Health Biotchnology's intrinsic value. More Info.Health Biotchnology Portfolio is rated top fund in price to earning among similar funds. It also is rated top fund in price to book among similar funds fabricating about 0.15 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Health Biotchnology Portfolio is roughly 6.84 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Health Biotchnology's earnings, one of the primary drivers of an investment's value.Health Biotchnology Systematic Risk
Health Biotchnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Health Biotchnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Health Biotchnology correlated with the market. If Beta is less than 0 Health Biotchnology generally moves in the opposite direction as compared to the market. If Health Biotchnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Health Biotchnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Health Biotchnology is generally in the same direction as the market. If Beta > 1 Health Biotchnology moves generally in the same direction as, but more than the movement of the benchmark.
Health Biotchnology March 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Health Biotchnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Health Biotchnology Portfolio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Health Biotchnology Portfolio based on widely used predictive technical indicators. In general, we focus on analyzing Health Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Health Biotchnology's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.7437 | |||
| Information Ratio | 0.04 | |||
| Maximum Drawdown | 3.4 | |||
| Value At Risk | (1.18) | |||
| Potential Upside | 1.17 |
Other Information on Investing in Health Mutual Fund
Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |